Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

New compounds may soon be tested to treat excessive hair growth in women.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Terazosin hydrochloride helps with BPH and blood pressure, but not more than the control.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Baricitinib and ritlecitinib are both effective and safe for treating severe alopecia areata.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Blocking certain brain processes reduces mating behavior in female rats.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Itraconazole helps improve tough skin infections but may not prevent them from coming back.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The combination treatment showed a higher response rate but no significant survival benefits.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.